Functional Balance Intervention for Multiple Sclerosis
(FBIinMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a Functional Balance Intervention (FBI) can aid individuals with Multiple Sclerosis (MS) in enhancing their physical and cognitive abilities. The trial consists of two parts: one in a lab and the other at home, both comparing FBI to stretching exercises. Individuals with MS who have not received physical therapy for over six months and experience balance or cognitive challenges may be suitable candidates. Participants will engage in exercise sessions twice a week for four months to determine if these interventions can enhance daily life activities. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve the quality of life for those with MS.
Do I have to stop taking my current medications for the trial?
The trial requires that you have been on stable disease-modifying therapy for at least 6 months, so you should not stop taking these medications. However, you cannot participate if you are taking certain sedatives, Alzheimer's or dementia medications, anti-depressants, or anxiety drugs.
What prior data suggests that this Functional Balance Intervention is safe for people with Multiple Sclerosis?
Research shows that the Functional Balance Intervention (FBI) is safe and well-tolerated for people with multiple sclerosis (MS). Previous studies have found that similar balance training programs, which include exercises like agility and strength training, can be safely used by people with MS. These programs aim to improve balance and mobility by gradually increasing in difficulty, ensuring participants are not pushed too hard too quickly.
This method has also been successful in treating other neurological conditions and in older adults, indicating it is a low-risk option. Past studies have reported no significant negative effects, suggesting that participants generally respond well to the treatment. While specific information on side effects for this intervention is limited, the lack of reported issues in similar programs is reassuring.
The trial is in its early stages, focusing on the treatment's safety and effectiveness. Although this means less detailed data might be available, the use of FBI in other situations provides some confidence in its safety for those considering joining the trial.12345Why are researchers excited about this trial?
Researchers are excited about the Functional Balance Intervention (FBI) for multiple sclerosis (MS) because it offers a fresh approach focused on enhancing physical agility and strength through home-based or lab-based exercises. Unlike typical treatments that often rely on medications like interferons and immunosuppressants to manage symptoms, the FBI emphasizes a holistic exercise regimen. This approach includes functional agility, dual-tasking, and vestibular exercises, which aim to improve balance and daily living activities. By potentially enhancing physical function and quality of life without the side effects of medication, this intervention could offer a significant advantage for those living with MS.
What evidence suggests that this trial's Functional Balance Intervention could be effective for multiple sclerosis?
Research has shown that Functional Balance Interventions (FBI) can help people with multiple sclerosis (MS) improve their physical abilities. In this trial, participants will join different arms to evaluate the effectiveness of FBI. Studies indicate that balance training with challenging tasks enhances movement and stability. Various studies have found a moderate improvement in balance and mobility, with a measured effect size of 0.46. While FBI might not significantly impact cognitive skills, it effectively boosts physical function. FBI includes exercises like agility, strength, and dual-tasking, which contribute to these positive results. Overall, FBI appears promising for improving physical symptoms in MS.13467
Who Is on the Research Team?
Tanvi Bhatt, PhD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for people with Multiple Sclerosis (MS) who can participate in a study to improve their balance and cognitive functions. Participants will be screened over the phone, then in person, and must be able to commit to twice-weekly sessions for four months either at a lab or from home.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-training Assessment
Participants undergo pre-training assessment and randomization into FBI or Stretching groups
Treatment
Participants receive either Functional Balance Intervention or Stretching for 4 months
Post-training Assessment
Participants are assessed for changes in physical and cognitive function after training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Functional Balance Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor